Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

PCVX – Vaxcyte, Inc.

Vaxcyte, Inc.
PCVX
$31.60
Name : Vaxcyte, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $4,068,879,360.00
EPSttm : -3.8
finviz dynamic chart for PCVX
Vaxcyte, Inc.
$31.60
3.40%
$1.04

Float Short %

10.08

Margin Of Safety %

Put/Call OI Ratio

0.24

EPS Next Q Diff

0.02

EPS Last/This Y

-0.48

EPS This/Next Y

-0.37

Price

31.55

Target Price

128.44

Analyst Recom

1

Performance Q

-62.06

Relative Volume

3.54

Beta

1.32

Ticker: PCVX




23 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-05PCVX73.90.737.7810364
2025-03-06PCVX74.810.7362.5010379
2025-03-07PCVX71.180.770.5010607
2025-03-10PCVX65.40.7717.0010608
2025-03-11PCVX69.840.780.0210679
2025-03-12PCVX73.20.770.7110768
2025-03-13PCVX73.060.780.7710867
2025-03-14PCVX74.40.790.1110939
2025-03-17PCVX75.670.802.9310958
2025-03-18PCVX74.750.690.0910520
2025-03-19PCVX76.090.686.4610662
2025-03-20PCVX74.550.640.1010404
2025-03-21PCVX74.720.630.2110429
2025-03-24PCVX73.760.960.416121
2025-03-25PCVX71.940.842.086951
2025-03-26PCVX68.611.021.577631
2025-03-27PCVX70.731.171.358609
2025-03-28PCVX69.441.240.039000
2025-03-31PCVX37.81.190.099447
2025-04-01PCVX32.240.300.1014430
2025-04-02PCVX33.650.211.2014365
2025-04-03PCVX30.550.230.8814893
2025-04-04PCVX31.520.240.7915073
DateSymbolLastP/C OIP/C VolTotal OI
23 items Current Page1 of 1




23 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-05PCVX73.90-8.1- -4.30
2025-03-06PCVX74.80-8.1- -4.30
2025-03-07PCVX71.19-8.1- -4.30
2025-03-10PCVX68.94-8.1- -4.30
2025-03-11PCVX69.81-8.1- -4.30
2025-03-12PCVX73.27-8.1- -4.30
2025-03-13PCVX73.02-8.1- -4.30
2025-03-14PCVX74.37-8.1- -4.30
2025-03-17PCVX75.23-8.1- -4.30
2025-03-18PCVX74.72-8.1- -4.30
2025-03-19PCVX76.14-8.1- -4.30
2025-03-20PCVX74.46-8.1- -4.30
2025-03-21PCVX74.68-8.1- -4.30
2025-03-24PCVX73.82-8.1- -4.30
2025-03-25PCVX71.90-8.1- -4.30
2025-03-26PCVX68.56-8.1- -4.30
2025-03-27PCVX70.72-8.1- -4.30
2025-03-28PCVX69.46-8.1- -4.30
2025-03-31PCVX37.76-8.1- -4.30
2025-04-01PCVX32.23-8.1- -4.30
2025-04-02PCVX33.69-8.1- -4.30
2025-04-03PCVX30.56-8.1- -4.28
2025-04-04PCVX31.55-8.1- -4.28
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
23 items Current Page1 of 1




23 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-05PCVX-7.293.7110.67
2025-03-06PCVX-6.913.7110.67
2025-03-07PCVX-6.933.7110.67
2025-03-10PCVX-7.043.9610.67
2025-03-11PCVX-7.043.9610.67
2025-03-12PCVX-7.043.969.86
2025-03-13PCVX-7.043.969.86
2025-03-14PCVX-7.043.969.86
2025-03-17PCVX-7.253.959.86
2025-03-18PCVX-7.253.959.86
2025-03-19PCVX-6.863.959.86
2025-03-20PCVX-6.673.959.86
2025-03-21PCVX-6.673.959.86
2025-03-24PCVX-6.673.939.86
2025-03-25PCVX-6.673.939.86
2025-03-26PCVX-6.673.9310.08
2025-03-27PCVX-6.673.9310.08
2025-03-28PCVX-6.673.9310.08
2025-03-31PCVX-6.673.9310.08
2025-04-01PCVX-6.613.9310.08
2025-04-02PCVX-6.613.9310.08
2025-04-03PCVX-6.613.9310.08
2025-04-04PCVX-4.963.9310.08
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
23 items Current Page1 of 1

Last Quarter Act. EPS

-1.01

Avg. EPS Est. Current Quarter

-0.92

Avg. EPS Est. Next Quarter

-0.99

Insider Transactions

-4.96

Institutional Transactions

3.93

Beta

1.32

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

11

Growth Score

20

Sentiment Score

2

Actual DrawDown %

73.9

Max Drawdown 5-Year %

Target Price

128.44

P/E

Forward P/E

PEG

P/S

P/B

1.19

P/Free Cash Flow

EPS

-3.88

Average EPS Est. Cur. Y​

-4.28

EPS Next Y. (Est.)

-4.65

Target Price Estimates Raised

Target Price Estimates Lowered

2

Profit Margin

Relative Volume

3.54

Return on Equity vs Sector %

-33.8

Return on Equity vs Industry %

-20.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

Vaxcyte, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 414
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD). The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV being developed for the prevention of IPD in adults and children. VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; and VAX-GI to prevent dysentery and shigellosis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
stock quote shares PCVX – Vaxcyte, Inc. Stock Price stock today
news today PCVX – Vaxcyte, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch PCVX – Vaxcyte, Inc. yahoo finance google finance
stock history PCVX – Vaxcyte, Inc. invest stock market
stock prices PCVX premarket after hours
ticker PCVX fair value insiders trading